Effects of N-acetylcysteine in an esophageal carcinogenesis model in rats treated with diethylnitrosamine and diethyldithiocarbamate

International Journal of Cancer

Volumn 98, Issue 4, 2002, Pages 493-497

  Balansky, Roumen M ^a   Ganchev, Gancho ^a   D'Agostini, Francesco ^b   De Flora, Silvio ^b  

^a National Oncology Center Bulgaria   (Bulgaria)

^b UNIVERSITY OF GENOA   (Italy)

Author keywords

Diethyldithiocarbamate; Esophageal tumors; Liver tumors; N acetylcysteine; N diethylnitrosamine

Indexed keywords

ACETYLCYSTEINE; CARCINOGEN; DIETHYLDITHIOCARBAMIC ACID; DIETHYLNITROSAMINE; GLUTATHIONE DERIVATIVE; NITROSAMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INCIDENCE; CARCINOGENESIS; CLINICAL PROTOCOL; CONTROLLED STUDY; DRUG EFFECT; ESOPHAGUS CARCINOMA; EXPERIMENTAL MODEL; FEMALE; LIVER CARCINOGENESIS; LIVER TUMOR; MALIGNANT TRANSFORMATION; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTECTION; RAT; SURVIVAL RATE;

ACETYLCYSTEINE; ANIMALS; DIETHYLNITROSAMINE; DITIOCARB; DRUG SYNERGISM; ESOPHAGEAL NEOPLASMS; ESOPHAGUS; FREE RADICAL SCAVENGERS; HYPERPLASIA; KERATOSIS; LIVER NEOPLASMS; RATS; RATS, INBRED STRAINS; SURVIVAL RATE;

EID: 0036533599     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.10215     Document Type: Article

References (47)

1. The changing epidemiology of esophageal cancer
2. Estimates of the worldwide incidence of 25 major cancers in 1990
3. Etiology of esophageal cancer: Some operative factors
4. Diet, reflux and the development of squamous cell carcinoma of the esophagus in Africa
5. Determinants of survival following the diagnosis of esophageal adenocarcinoma (United States)
6. Some aspects of the epidemiology and etiology of esophageal cancer with particular emphasis on the Transkei, South Africa
7. Exposure to high concentrations of nitrosamines and cancer mortality among a cohort of rubber workers
8. Alcohol drinking
9. DNA alterations in rat organs following chronic exposure to cigarette smoke or ethanol ingestion
10. Perspectives on cancer chemoprevention research and drug development
11. Esophageal carcinogenesis in the rat: A model for aerodigestive tract cancer
12. Modulation of diethylnitrosamine carcinogenesis in rat liver an esophagus
13. Mechanisms of N-acetylcysteine in the prevention of DNA damage and cancer, with special reference to smoking-related and-points
14. Clinical development plans for cancer chemopreventive agents: N-acetylcysteine
15. Chemoprevention by N-acetylcysteine of urethane-induced clastogenicity and lung tumors in mice
16. Roles of cytochrome P450IIE1 in the dealkylation and denitrosation of N-nitrosodimethylamine and N-nitrosodiethylamine in rat liver microsomes
17. Participation of rat liver cytochrome P450 2E1 in the activation of N-nitrosodimethylamine and N-nitrosodiethylamine to products genotoxic in an acetyltransferase-overexpressing Salmonella typhimurium strain (NM2009)
18. Influence of disulfiram on the organotropy of the carcinogenic effect of dimethylnitrosamine and diethylnitrosamine in rats
19. Influence of a prolonged treatment with disulfiram and D(-)penicillamine on nitrosodiethylamine-induced biological and biochemical effect in rats. I. Investigations on the drug metabolizing system
20. Sugar-linked dithiocarbamates as modulators of metabolic and genotoxic properties of N-nitroso compounds
21. The sequential analysis of liver cell necrosis: Inhibition of diethylnitrosamine- and dimethylnitrosamine-induced acute liver cell death by post-treatment with diethyldithiocarbamate
22. Characterization of cytochrome P450 expression in human esophageal mucosa
23. 6- and 7-methylguanine in DNA of N-nitroso-N-methylbenzylamine-treated rats is restricted to non-target organs for N-nitroso-N-methylbenzylamine-induced carcinogenesis
24. 6-alkylguanine-DNA-methyl-transferase in rat esophagus and liver
25. Ethanol and dimethylnitrosamine and diethylnitrosamine metabolism and disposition in the rat. Possible relevance to the influence of ethanol on human cancer incidence
26. Influence of dithiocarbamates on the metabolism and toxicity of N-nitrosodimethylamine in rats
27. Mechanisms of inhibitors of mutagenesis and carcinogenesis. Classification and overview
28. Organ specificity in the microsomal activation and toxicity of N-nitrosomethylbenzylamine in various species
29. Some N-nitroso compounds
30. Chemoprevention of diethylnitrosamine-induced liver foci and hepatocellular adenomas in C3H mice
31. Effects of aminothiols in 2-acetylaminofluorene-treated rats. I. Damage and repair of liver DNA, hyperplastic foci and Zymbal gland tumors
32. Heterologous expression of rat P450 2E1 in a mammalian cell line: In situ metabolism and cytotoxicity of N-nitrosodimethylamine
33. Antioxidants reduce cyclooxygenase-2 expression, prostaglandin production and proliferation in colorectal cancer cells
34. Benzo(a)pyrene induces the transcription of cyclooxygenase-2 in vascular smooth muscle cells. Evidence for the involvement of extracellular signal-regulated kinase and NF-κB
35. Regulation of cyclooxygenase-2 expression in human osteoblastic cells by N-acetylcysteine
36. Cyclooxygenase-2 expression in human esophageal carcinoma
37. Upregulation of cyclooxygenase-2 squamous carcinogenesis of the esophagus
38. Suppression of N-nitrosomethyl-benzylamine (NMBA)-induced esophageal tumorigenesis in F344 rats by JTE-522, a selective COX-2 inhibitor
39. Use of aspirin and other nonsteroidal anti-inflammatory drugs and risk of esophageal and gastric cancer
40. Effects of N-acetylcysteine on experimentally induced esophageal lye injury
41. Chemopreventive potential of fumaric acid, N-acetylcysteine, N-(4-hydroxyphenyl) retinamide and β-carotene for tobacco-nitrosamine-induced lung tumors in A/J mice
42. P53-independent inhibition of proliferation and p21 (WAF1/Cip1)-modulated induction of cell death by the antioxidants N-acetylcysteine and vitamin E
43. Proliferation of cultured human astrocytoma cells in response to an oxidant and antioxidant
44. N-acetylcysteine suppression of the proliferative index in the colon of patients with previous adenomatous colonic polyps
45. 1 prolongation by the chemopreventive agent N-acetylcysteine